AVECHO BIOTECHNOLOGY LIMITED - Announcements

Market Cap $12.67M Add to my watchlist

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company... Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM. More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Combining science, nature and human compassion, Little Green Pharma (ASX:LGP) are committed to improving the quality of life for sufferers of debilitating chronic conditions. NEWS: Little Green Pharma shares surge as Germany legalises Cannabis.

Announcements

Filter Results

All Price Sensitive Only

AVE	CEO Quarterly Update Teleconference		16/02/16	43.53KB	Share
AVE	Phosphagenics - February 2016 Newsletter		16/02/16	811.03KB	Share
AVE	Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial	PRICE SENSITIVE	29/01/16	610.51KB	Share
AVE	Positive Results for Weaner Pig Feed Efficiency Trial	PRICE SENSITIVE	20/01/16	51.28KB	Share
AVE	Appendix 3B Notice Reconciliation of Non-Quoted Securities		12/01/16	194.81KB	Share
AVE	Phosphagenics Initiates Arbitration Against Mylan		06/01/16	49.14KB	Share
AVE	Change in substantial holding		06/01/16	147.51KB	Share
AVE	Response to ASX Price Query	PRICE SENSITIVE	05/01/16	1.08MB	Share
AVE	Phosphagenics' PHN Trial Completes Enrolment and Dosing	PRICE SENSITIVE	17/12/15	339.45KB	Share
AVE	Change of Company Secretary		04/12/15	39.24KB	Share
AVE	Phosphagenics Initiates Grower/Finisher Pig Study	PRICE SENSITIVE	03/12/15	48.62KB	Share
AVE	Change in substantial holding		13/11/15	146.53KB	Share
AVE	Receipt of R&D Tax Incentive	PRICE SENSITIVE	11/11/15	38.88KB	Share
AVE	Change in substantial holding		09/11/15	148.24KB	Share
AVE	Phosphagenics Investor presentation - Australian Roadshow		04/11/15	860.08KB	Share
AVE	Change in substantial holding		02/11/15	155.39KB	Share
AVE	Phosphagenics - October 2015 Newsletter		28/10/15	3.15MB	Share
AVE	Quarterly Shareholder Update teleconference		23/10/15	327.3KB	Share
AVE	Development Agreement for TPM Oxymorphone Patch	PRICE SENSITIVE	22/10/15	44.2KB	Share
AVE	Phosphagenics Restructures	PRICE SENSITIVE	12/10/15	50.93KB	Share
AVE	Phosphagenics Begins Animal Health & Nutrition Program	PRICE SENSITIVE	28/09/15	73.86KB	Share
AVE	June 2015 Half-year Appendix 4D and Financial report	PRICE SENSITIVE	31/08/15	1.78MB	Share
AVE	Appendix 3Y Change in Directors Interest Dr R Murdoch		06/08/15	92.8KB	Share
AVE	Reconciliation of Non-quoted Securities and Appendix 3B		06/08/15	304.95KB	Share
AVE	Appendix 3Z - Final Directors Interest Notice - Mr H Rosen		10/07/15	136.3KB	Share
AVE	Phosphagenics July 2015 Newsletter		09/07/15	1.16MB	Share
AVE	Executive Director and Founder Steps Down		08/07/15	39.72KB	Share
AVE	POH - Quarterly Shareholder Update - Teleconference		01/07/15	85.93KB	Share
AVE	Appointment of Consultant to Assist in Commercialising TPM		09/06/15	43.89KB	Share
AVE	2015 Annual General Meeting Results		19/05/15	152.25KB	Share
AVE	2015 AGM Chairmans and CEO Presentations		18/05/15	272.38KB	Share
AVE	Final Directors Interest Notice - Appendix 3Z		14/05/15	204.64KB	Share
AVE	Oxymorphone Patch Program Update	PRICE SENSITIVE	14/05/15	48.36KB	Share
AVE	Resignation of Chairman - Mr L Gozlan		12/05/15	40.21KB	Share
AVE	2014 Annual Report and 2015 AGM documentation		17/04/15	4.79MB	Share
AVE	Appendix 3X Notices - 3		17/04/15	193.4KB	Share
AVE	POH Oxycodone Patch Dosing in Phase 2 Clinical Trial	PRICE SENSITIVE	17/04/15	336.72KB	Share
AVE	Phosphagenics Appoints Three New Directors		13/04/15	44.41KB	Share
AVE	Animal Health Nutrition License Agreement signed	PRICE SENSITIVE	25/03/15	49.72KB	Share
AVE	Response to ASX Price Query	PRICE SENSITIVE	12/03/15	206.15KB	Share
AVE	December 2014 Preliminary Final Report and Financial Report	PRICE SENSITIVE	26/02/15	692.8KB	Share
AVE	POH Decides to Put its BioElixia Cosmetic Brand Up For Sale	PRICE SENSITIVE	25/02/15	53.16KB	Share
AVE	Phosphagenics Appoints Dr Ross Murdoch as CEO	PRICE SENSITIVE	14/01/15	217.99KB	Share
AVE	Ethics Approval -Topical Phase 2 TPM Oxycodone Patch Trial	PRICE SENSITIVE	08/12/14	68.04KB	Share
AVE	Phosphagenics November Newsletter		05/11/14	1.52MB	Share
AVE	Phosphagenics Launches New Logo and Website		05/11/14	47.68KB	Share
AVE	Director's Change of Interest Notice - Dr G Cauwenbergh		15/10/14	228.65KB	Share
AVE	Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne	PRICE SENSITIVE	07/10/14	51.66KB	Share
AVE	Form 604 Change Substantial Shareholding Mr H Rosen		01/09/14	1.44MB	Share
AVE	Section 708A Notice - Equity Raising - 51 million new shares		01/09/14	138.38KB	Share
AVE	Confirmation - Allotment of 51 million new ordinary shares		01/09/14	158.13KB	Share
AVE	June 2014 App 4D Half Yearly Report and Financial Report	PRICE SENSITIVE	27/08/14	7.5MB	Share
AVE	General Meeting Results		26/08/14	372.81KB	Share
AVE	First IND Enabling Study for TPM Oxymorphone Completed	PRICE SENSITIVE	11/08/14	48.99KB	Share
AVE	Allotment of Share Purchase Plan New Shares		06/08/14	173.93KB	Share
AVE	Share Purchase Plan Closed Oversubscribed		05/08/14	52.19KB	Share
AVE	Opioid Patch Program Update	PRICE SENSITIVE	28/07/14	52.6KB	Share
AVE	Share Purchase Plan Extension of Closing Date to 01 08 14		25/07/14	137.87KB	Share
AVE	General Meeting Documentation - Proxy Form		25/07/14	580.6KB	Share
AVE	Form 605 Notice of ceasing to be a substantial shareholder		23/07/14	824.31KB	Share
AVE	Section 708A Notice - Equity Raising - 153 million shares		18/07/14	142.94KB	Share
AVE	Confirmation - allotment of 153 million new shares		18/07/14	158.52KB	Share
AVE	POH - Share Purchase Plan documentation		15/07/14	402.34KB	Share
AVE	POH - SPP - Notice Under ASIC Class Order 09-425		11/07/14	129.5KB	Share
AVE	Phosphagenics Appendix 3B Notice - Equity Capital Raising		11/07/14	377.88KB	Share
AVE	Phosphagenics $19.3 million Capital raising	PRICE SENSITIVE	11/07/14	46.99KB	Share
AVE	Trading Halt	PRICE SENSITIVE	09/07/14	181.95KB	Share
AVE	Strengthens Partnership with Le Metier de Beaute Cosmetics		12/06/14	42.89KB	Share
AVE	Appendix 3Y Notices -3- Change in Directors Interest		03/06/14	232.62KB	Share
AVE	Appendix 3B Notice - Issue of Options to Directors		03/06/14	320.17KB	Share
AVE	2014 AGM Results		23/05/14	671.21KB	Share
AVE	2014 AGM Addresses - Presentations		23/05/14	1.06MB	Share
AVE	POH Topical Oxycodone Patch Alleviates Pain in Racehorses	PRICE SENSITIVE	21/05/14	321.98KB	Share
AVE	POH Presents Transdermal Oxymorphone Data in USA		05/05/14	594.4KB	Share
AVE	Enrolments Completed for Phase 2 Acne Treatment Trial	PRICE SENSITIVE	23/04/14	118.43KB	Share
AVE	2013 Annual Report and 2014 AGM Documentation		17/04/14	3.66MB	Share
AVE	Webcast Investment Presentation		03/04/14	822.9KB	Share
AVE	March 2014 NEWSLETTER		17/03/14	1.39MB	Share
AVE	Appendix 3X and Appendix 3Y Notices		04/03/14	302.1KB	Share
AVE	Appointment of Non-Executive Directors		03/03/14	45.55KB	Share
AVE	December 2013 Appendix 4E - Annual Financial Report	PRICE SENSITIVE	28/02/14	428.03KB	Share
AVE	Novartis Launches Voveran TPM Gel in India	PRICE SENSITIVE	21/01/14	57.28KB	Share
AVE	Reconciliation of Non-Quoted Securities - Conditional Rights		20/12/13	270.98KB	Share
AVE	Phosphagenics - TPM in Dairy Feed Inclusion Technology	PRICE SENSITIVE	12/12/13	144.76KB	Share
AVE	POH Signs Further Deed of Settlement with Final Parties	PRICE SENSITIVE	08/11/13	126.45KB	Share
AVE	Phosphagenics Issues Proceedings Against Former Employee		31/10/13	37.98KB	Share
AVE	Phosphagenics Signs Deed of Settlement with Dr Ogru	PRICE SENSITIVE	30/10/13	186.67KB	Share
AVE	Phosphagenics' Oxymorphone Patch Success	PRICE SENSITIVE	24/10/13	48.29KB	Share
AVE	Oxymorphone Pain Relief Patch - Multi-Dose Trial	PRICE SENSITIVE	19/09/13	170.16KB	Share
AVE	September 2013 Newsletter		10/09/13	5.81MB	Share
AVE	Reconciliation of Non-Quoted Securities		04/09/13	167.72KB	Share
AVE	POH - TPM Drug Delivery Technology - PAINWeek 2013 in USA		03/09/13	41.27KB	Share
AVE	June 2013 Appendix 4D Half Year Financial Report - Accounts	PRICE SENSITIVE	30/08/13	767.23KB	Share
AVE	Sale of Former CEO Shares		05/08/13	36.38KB	Share
AVE	Phosphagenics Pain Program Update	PRICE SENSITIVE	26/07/13	46.41KB	Share
AVE	Misappropriations Investigation - Clarification		25/07/13	135.79KB	Share
AVE	Appendix 3Z Final Director's Interest Notice - Dr E Ogru		24/07/13	275.37KB	Share
AVE	Invoicing and Accounting Misappropriations Investigation	PRICE SENSITIVE	24/07/13	42.12KB	Share
AVE	Resignation of Executive Director		22/07/13	36.9KB	Share
AVE	Phosphagenics to Launch Phase 2 Acne Treatment Trial	PRICE SENSITIVE	12/07/13	144.21KB	Share

AVE CEO Quarterly Update Teleconference
16/02/16		43.53KB	Share
AVE Phosphagenics - February 2016 Newsletter
16/02/16		811.03KB	Share
AVE Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial
29/01/16	PRICE SENSITIVE	610.51KB	Share
AVE Positive Results for Weaner Pig Feed Efficiency Trial
20/01/16	PRICE SENSITIVE	51.28KB	Share
AVE Appendix 3B Notice Reconciliation of Non-Quoted Securities
12/01/16		194.81KB	Share
AVE Phosphagenics Initiates Arbitration Against Mylan
06/01/16		49.14KB	Share
AVE Change in substantial holding
06/01/16		147.51KB	Share
AVE Response to ASX Price Query
05/01/16	PRICE SENSITIVE	1.08MB	Share
AVE Phosphagenics' PHN Trial Completes Enrolment and Dosing
17/12/15	PRICE SENSITIVE	339.45KB	Share
AVE Change of Company Secretary
04/12/15		39.24KB	Share
AVE Phosphagenics Initiates Grower/Finisher Pig Study
03/12/15	PRICE SENSITIVE	48.62KB	Share
AVE Change in substantial holding
13/11/15		146.53KB	Share
AVE Receipt of R&D Tax Incentive
11/11/15	PRICE SENSITIVE	38.88KB	Share
AVE Change in substantial holding
09/11/15		148.24KB	Share
AVE Phosphagenics Investor presentation - Australian Roadshow
04/11/15		860.08KB	Share
AVE Change in substantial holding
02/11/15		155.39KB	Share
AVE Phosphagenics - October 2015 Newsletter
28/10/15		3.15MB	Share
AVE Quarterly Shareholder Update teleconference
23/10/15		327.3KB	Share
AVE Development Agreement for TPM Oxymorphone Patch
22/10/15	PRICE SENSITIVE	44.2KB	Share
AVE Phosphagenics Restructures
12/10/15	PRICE SENSITIVE	50.93KB	Share
AVE Phosphagenics Begins Animal Health & Nutrition Program
28/09/15	PRICE SENSITIVE	73.86KB	Share
AVE June 2015 Half-year Appendix 4D and Financial report
31/08/15	PRICE SENSITIVE	1.78MB	Share
AVE Appendix 3Y Change in Directors Interest Dr R Murdoch
06/08/15		92.8KB	Share
AVE Reconciliation of Non-quoted Securities and Appendix 3B
06/08/15		304.95KB	Share
AVE Appendix 3Z - Final Directors Interest Notice - Mr H Rosen
10/07/15		136.3KB	Share
AVE Phosphagenics July 2015 Newsletter
09/07/15		1.16MB	Share
AVE Executive Director and Founder Steps Down
08/07/15		39.72KB	Share
AVE POH - Quarterly Shareholder Update - Teleconference
01/07/15		85.93KB	Share
AVE Appointment of Consultant to Assist in Commercialising TPM
09/06/15		43.89KB	Share
AVE 2015 Annual General Meeting Results
19/05/15		152.25KB	Share
AVE 2015 AGM Chairmans and CEO Presentations
18/05/15		272.38KB	Share
AVE Final Directors Interest Notice - Appendix 3Z
14/05/15		204.64KB	Share
AVE Oxymorphone Patch Program Update
14/05/15	PRICE SENSITIVE	48.36KB	Share
AVE Resignation of Chairman - Mr L Gozlan
12/05/15		40.21KB	Share
AVE 2014 Annual Report and 2015 AGM documentation
17/04/15		4.79MB	Share
AVE Appendix 3X Notices - 3
17/04/15		193.4KB	Share
AVE POH Oxycodone Patch Dosing in Phase 2 Clinical Trial
17/04/15	PRICE SENSITIVE	336.72KB	Share
AVE Phosphagenics Appoints Three New Directors
13/04/15		44.41KB	Share
AVE Animal Health Nutrition License Agreement signed
25/03/15	PRICE SENSITIVE	49.72KB	Share
AVE Response to ASX Price Query
12/03/15	PRICE SENSITIVE	206.15KB	Share
AVE December 2014 Preliminary Final Report and Financial Report
26/02/15	PRICE SENSITIVE	692.8KB	Share
AVE POH Decides to Put its BioElixia Cosmetic Brand Up For Sale
25/02/15	PRICE SENSITIVE	53.16KB	Share
AVE Phosphagenics Appoints Dr Ross Murdoch as CEO
14/01/15	PRICE SENSITIVE	217.99KB	Share
AVE Ethics Approval -Topical Phase 2 TPM Oxycodone Patch Trial
08/12/14	PRICE SENSITIVE	68.04KB	Share
AVE Phosphagenics November Newsletter
05/11/14		1.52MB	Share
AVE Phosphagenics Launches New Logo and Website
05/11/14		47.68KB	Share
AVE Director's Change of Interest Notice - Dr G Cauwenbergh
15/10/14		228.65KB	Share
AVE Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne
07/10/14	PRICE SENSITIVE	51.66KB	Share
AVE Form 604 Change Substantial Shareholding Mr H Rosen
01/09/14		1.44MB	Share
AVE Section 708A Notice - Equity Raising - 51 million new shares
01/09/14		138.38KB	Share
AVE Confirmation - Allotment of 51 million new ordinary shares
01/09/14		158.13KB	Share
AVE June 2014 App 4D Half Yearly Report and Financial Report
27/08/14	PRICE SENSITIVE	7.5MB	Share
AVE General Meeting Results
26/08/14		372.81KB	Share
AVE First IND Enabling Study for TPM Oxymorphone Completed
11/08/14	PRICE SENSITIVE	48.99KB	Share
AVE Allotment of Share Purchase Plan New Shares
06/08/14		173.93KB	Share
AVE Share Purchase Plan Closed Oversubscribed
05/08/14		52.19KB	Share
AVE Opioid Patch Program Update
28/07/14	PRICE SENSITIVE	52.6KB	Share
AVE Share Purchase Plan Extension of Closing Date to 01 08 14
25/07/14		137.87KB	Share
AVE General Meeting Documentation - Proxy Form
25/07/14		580.6KB	Share
AVE Form 605 Notice of ceasing to be a substantial shareholder
23/07/14		824.31KB	Share
AVE Section 708A Notice - Equity Raising - 153 million shares
18/07/14		142.94KB	Share
AVE Confirmation - allotment of 153 million new shares
18/07/14		158.52KB	Share
AVE POH - Share Purchase Plan documentation
15/07/14		402.34KB	Share
AVE POH - SPP - Notice Under ASIC Class Order 09-425
11/07/14		129.5KB	Share
AVE Phosphagenics Appendix 3B Notice - Equity Capital Raising
11/07/14		377.88KB	Share
AVE Phosphagenics $19.3 million Capital raising
11/07/14	PRICE SENSITIVE	46.99KB	Share
AVE Trading Halt
09/07/14	PRICE SENSITIVE	181.95KB	Share
AVE Strengthens Partnership with Le Metier de Beaute Cosmetics
12/06/14		42.89KB	Share
AVEAppendix 3Y Notices -3- Change in Directors Interest
03/06/14		232.62KB	Share
AVEAppendix 3B Notice - Issue of Options to Directors
03/06/14		320.17KB	Share
AVE2014 AGM Results
23/05/14		671.21KB	Share
AVE2014 AGM Addresses - Presentations
23/05/14		1.06MB	Share
AVEPOH Topical Oxycodone Patch Alleviates Pain in Racehorses
21/05/14	PRICE SENSITIVE	321.98KB	Share
AVEPOH Presents Transdermal Oxymorphone Data in USA
05/05/14		594.4KB	Share
AVEEnrolments Completed for Phase 2 Acne Treatment Trial
23/04/14	PRICE SENSITIVE	118.43KB	Share
AVE2013 Annual Report and 2014 AGM Documentation
17/04/14		3.66MB	Share
AVEWebcast Investment Presentation
03/04/14		822.9KB	Share
AVEMarch 2014 NEWSLETTER
17/03/14		1.39MB	Share
AVEAppendix 3X and Appendix 3Y Notices
04/03/14		302.1KB	Share
AVEAppointment of Non-Executive Directors
03/03/14		45.55KB	Share
AVEDecember 2013 Appendix 4E - Annual Financial Report
28/02/14	PRICE SENSITIVE	428.03KB	Share
AVENovartis Launches Voveran TPM Gel in India
21/01/14	PRICE SENSITIVE	57.28KB	Share
AVEReconciliation of Non-Quoted Securities - Conditional Rights
20/12/13		270.98KB	Share
AVEPhosphagenics - TPM in Dairy Feed Inclusion Technology
12/12/13	PRICE SENSITIVE	144.76KB	Share
AVEPOH Signs Further Deed of Settlement with Final Parties
08/11/13	PRICE SENSITIVE	126.45KB	Share
AVEPhosphagenics Issues Proceedings Against Former Employee
31/10/13		37.98KB	Share
AVEPhosphagenics Signs Deed of Settlement with Dr Ogru
30/10/13	PRICE SENSITIVE	186.67KB	Share
AVEPhosphagenics' Oxymorphone Patch Success
24/10/13	PRICE SENSITIVE	48.29KB	Share
AVEOxymorphone Pain Relief Patch - Multi-Dose Trial
19/09/13	PRICE SENSITIVE	170.16KB	Share
AVESeptember 2013 Newsletter
10/09/13		5.81MB	Share
AVEReconciliation of Non-Quoted Securities
04/09/13		167.72KB	Share
AVEPOH - TPM Drug Delivery Technology - PAINWeek 2013 in USA
03/09/13		41.27KB	Share
AVEJune 2013 Appendix 4D Half Year Financial Report - Accounts
30/08/13	PRICE SENSITIVE	767.23KB	Share
AVESale of Former CEO Shares
05/08/13		36.38KB	Share
AVEPhosphagenics Pain Program Update
26/07/13	PRICE SENSITIVE	46.41KB	Share
AVEMisappropriations Investigation - Clarification
25/07/13		135.79KB	Share
AVEAppendix 3Z Final Director's Interest Notice - Dr E Ogru
24/07/13		275.37KB	Share
AVEInvoicing and Accounting Misappropriations Investigation
24/07/13	PRICE SENSITIVE	42.12KB	Share
AVEResignation of Executive Director
22/07/13		36.9KB	Share
AVEPhosphagenics to Launch Phase 2 Acne Treatment Trial
12/07/13	PRICE SENSITIVE	144.21KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 0.4¢		Change 0.001(14.3%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$1.766K	484.8K

Buyers (Bids)

No.	Vol.	Price($)
37	98067012	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	21260167	12

View Market Depth

No.	Vol.	Price($)
37	98067012	0.003
21	66185176	0.002
9	12500009	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	21260167	12
0.005	56661878	28
0.006	22945872	16
0.007	14212721	8
0.008	5858888	5

Last trade - 16.10pm 02/05/2024 (20 minute delay)


Last 0.4¢		Change 0.001 ( 14.3 %)
Open	High	Low	Volume
0.4¢	0.4¢	0.4¢	800000
Last updated 13.59pm 02/05/2024 ?

AVE (ASX) Chart

AVECHO BIOTECHNOLOGY LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories